Metabolic and laboratory effects of icodextrin.
Gokal
Ram
R
Manchester Royal Infirmary, Manchester, England, United Kingdom.
Moberly
James
J
Lindholm
Bengt
B
Mujais
Salim
S
D000042:Absorption / Q000187:drug effects; D015314:Dialysis Solutions / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004347:Drug Interactions; D005936:Glucans / Q000009:adverse effects / Q000627:therapeutic use*; D005947:Glucose / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D000077607:Icodextrin; D007274:Injections, Intraperitoneal; D007328:Insulin / Q000008:administration & dosage; D008660:Metabolism / Q000187:drug effects*
D015314:Dialysis Solutions; D005936:Glucans; D007004:Hypoglycemic Agents; D007328:Insulin; D000077607:Icodextrin; D005947:Glucose